Literature DB >> 18929940

Detection and management of pre-existing cognitive impairment and associated behavioral symptoms in the Intensive Care Unit.

Hochang B Lee1, Candyce J DeLoatch, SeongJin Cho, Paul Rosenberg, Simon C Mears, Frederick E Sieber.   

Abstract

Recent increase in both the elderly population and associated incidence of dementia are of critical importance to patient care in ICUs in the United States. Identification of pre-existing cognitive impairment, such as mild cognitive impairment and dementia, could prevent delirium and associated morbidity and mortality in the ICU. Additionally, noncognitive behavioral symptoms, such as depression, psychosis, agitation, and catastrophic reactions, are common in patients with pre-existing cognitive impairment. Detection and management of noncognitive behavioral symptoms associated with MRI and dementia in ICU leads to improved delivery of life-saving critical care.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929940      PMCID: PMC2610456          DOI: 10.1016/j.ccc.2008.05.006

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  46 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.

Authors:  Pierre N Tariot; Rema Raman; Laura Jakimovich; Lon Schneider; Anton Porsteinsson; Ronald Thomas; Jacobo Mintzer; Ronald Brenner; Kim Schafer; Leon Thal
Journal:  Am J Geriatr Psychiatry       Date:  2005-11       Impact factor: 4.105

3.  A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease.

Authors:  Louis A Profenno; Laura Jakimovich; Connie J Holt; Anton Porsteinsson; Pierre N Tariot
Journal:  Curr Alzheimer Res       Date:  2005-12       Impact factor: 3.498

Review 4.  Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.

Authors:  Daniel Weintraub; Howard I Hurtig
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

Review 5.  Delirium in older persons.

Authors:  Sharon K Inouye
Journal:  N Engl J Med       Date:  2006-03-16       Impact factor: 91.245

6.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

Authors:  J E Graham; K Rockwood; B L Beattie; R Eastwood; S Gauthier; H Tuokko; I McDowell
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

7.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

8.  Progression to dementia in patients with isolated memory loss.

Authors:  J Bowen; L Teri; W Kukull; W McCormick; S M McCurry; E B Larson
Journal:  Lancet       Date:  1997-03-15       Impact factor: 79.321

9.  Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.

Authors:  N C Fox; E K Warrington; A L Seiffer; S K Agnew; M N Rossor
Journal:  Brain       Date:  1998-09       Impact factor: 13.501

10.  Characteristics associated with delirium in older patients in a medical intensive care unit.

Authors:  Margaret A Pisani; Terrence E Murphy; Peter H Van Ness; Katy L B Araujo; Sharon K Inouye
Journal:  Arch Intern Med       Date:  2007 Aug 13-27
View more
  2 in total

1.  Neurocognitive problems in critically ill older adults: the importance of history.

Authors:  Judith A Tate; Mary Beth Happ
Journal:  Geriatr Nurs       Date:  2011 Jul-Aug       Impact factor: 2.361

Review 2.  Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms.

Authors:  Cina Sasannejad; E Wesley Ely; Shouri Lahiri
Journal:  Crit Care       Date:  2019-11-12       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.